StemFit™ Basic05
StemFit™ Basic05 is a next-generation, Animal Origin-Free (AOF) medium developed for scalable hPSC manufacturing. Compatible with both 2D adherent and 3D suspension culture, it enables a streamlined workflow from cell expansion to process scale-up using a single medium. Designed to deliver robust growth, uniform spheroid formation, and high reproducibility, Basic05 supports the transition from research to clinical manufacturing while reducing process complexity and development burden. StemFit™ Basic05 does not contain bFGF.
Key Benefits

Scalable Expansion
Enables scale-up through suspension culture. Supports culture process design from early-stage development with manufacturing in mind.

Differentiation Potential
PSCs cultured in Basic05 retain their differentiation capability, and have been confirmed to be capable of differentiation directly from 3D aggregates.

Seamless 2D to 3D Culture
Basic05 supports both 2D and 3D culture. The use of a single medium across culture modes minimizes process re-development and optimization associated with media changes.

Animal Origin-Free
AOF formulation reduces risks associated with undefined components. Designed to meet the requirements for clinical applications, enabling consistent use from research through clinical development.
Data Figures
- Expansion Capability and
Its Consistency Across
Cell Lines - Viability and
Uniform Spheroid - Flexible Workflow
- Scalability and
Usability Among
Various Culture Reactors - Differentiation Potential
- 2D Performance
Expansion Capability and Its Consistency Across Cell Lines
Basic05 supports strong and reproducible expansion of human iPSCs across multiple cell lines in 3D culture. High growth performance is maintained over passages, while pluripotency remains stable.
(A) Method
Using Basic05 and two competitor media (Medium-A and Medium-B), three human iPSC lines were cultured in 3D under orbital shaking in 125 mL flasks for up to four passages, and growth rate and pluripotency were evaluated.

(B) Cumulative fold expansion in 3D culture of each human iPSC line (four passages).

(C) OCT4-positive rate of each human iPSC line (at each passage).

Basic03 refers to StemFit™ Basic03, a 2D culture medium for hPSC expansion.
Viability and Uniform Spheroid
High cell viability and uniform spheroid formation are critical for stable suspension culture and scalable processes.With Basic05, high cell viability and uniform spheroid formation were observed across multiple human iPSC lines, along with maintenance of a normal karyotype. These results demonstrate that Basic05 enables stable and reproducible culture while maintaining cell quality.
(A) High cell viability across multiple human iPSC lines
Cell viability was evaluated using Vi-CELL and NC-200 across Basic05 and competitor media (Medium-A and Medium-B). Basic05 demonstrated high viability at both Day 1 and Day 3 in cells at passage 3.

(B) Uniform spheroid formation
Basic05 enables uniform spheroid formation with fewer dead cells (Passage 3, Day 1).

(C) Normal karyotype analysis of cells cultured in Basic05
Karyotype analysis at Passage 4 confirmed a normal karyotype in all three iPSC lines cultured in Basic05.
Flexible Workflow
Basic05 provides flexibility in culture scheduling and improves operational efficiency.
Comparable expansion was achieved even when weekend feeding was skipped, in addition to daily feeding conditions. This allows flexible culture schedules based on experimental needs and operational constraints.
As a result, weekend work and labor can be reduced while maintaining stable cell growth. This flexibility is supported not only by the performance of Basic05, but also by the excellent thermal stability of PG-011.
(A) Cumulative cell expansion under different medium change frequencies
Scalability and Usability Among Various Culture Reactors
Basic05 is compatible with a wide range of bioreactors, enabling flexible, platform-independent process development and a smooth transition from research to manufacturing scale, while minimizing re-optimization and technology transfer burden.
Using Basic05, a seamless 2D-to-3D culture process was established and scaled up to 1.5 L, achieving consistent 3–7 fold expansion per passage and stable cell growth from approximately 6 x10⁶ to 1.2 × 10⁹ cells (~200-fold expansion), while maintaining uniform aggregates and high pluripotency.
(A) Scalability Test Method
Over four passages (20 days), scale-up was evaluated by starting from 2D culture and stepwise transitioning to a shaker platform, spinner flask, and vertical-wheel reactor.

(B) Aggregate morphology of human iPSC line
(1383D2) at the end of each passage
(C) Cell growth rate across suspension
culture vessels
(D) Expression analysis of the pluripotency marker OCT4
(E) Cell number over time in 3D culture
Differentiation Potential
(A) Directed differentiation to three germ layers
Basic05 supports the maintenance of differentiation potential after 3D suspension culture.After 3D suspension culture using Basic05, iPSCs demonstrated efficient differentiation into all three germ layers, with lineage-specific marker expression confirmed across all three lineages.

(B) Directed differentiation to hematopoietic progenitor cells via PSC aggregates
Basic05 enables the direct transfer of PSC aggregates from expansion to differentiation, supporting a simplified and scalable workflow.PSC aggregates cultured in suspension with Basic05 were directly differentiated into hematopoietic progenitor cells (HPCs).

2D Performance
Basic05 enables a seamless transition from standard 2D culture to 3D suspension culture using a single medium, improving process development efficiency and reducing the need for re-optimization.In 2D culture, Basic05 showed strong growth and maintained pluripotency, with performance comparable to or better than conventional media.
(A) Method
Basic05 supplemented with 100 ng/mL bFGF was used to culture three human iPSC lines (1383D2, 201B7, and 1210B2) in 2D. Cells were passaged four times, and growth rate and pluripotency (OCT4-positive rate) were evaluated (7 days per passage).

(B) Growth performance across three iPSC lines
Cumulative expansion in 2D culture was evaluated for each cell line using Basic05.Basic05 demonstrated growth performance comparable to or better than Basic03 across all cell lines, confirming its strong performance as a 2D culture medium.

(C) OCT4-positive rate after four passages
Basic03 refers to StemFit™ Basic03,
a 2D culture medium for hPSC expansion.
StemFit™ Basic05
FAQ
- Is supplementation with bFGF required? This medium does not contain bFGF. As bFGF signaling is required to maintain the undifferentiated state of iPS cells, supplementation with either bFGF or an FGF2 alternative (PG-011) is required. We recommend the use of PG-011.
- Where can I purchase PG-011?
PG-011 is available from PeptiGrowth Co., Ltd. For product information, please visit: https://peptigrowth.com/products/pg-011/

- Can PG-011 be used for clinical applications?
In addition to supplying PG-011 for research use, PeptiGrowth also offers bulk supply and GMP-grade products intended for use in regenerative medicine and cell therapy manufacturing. For detailed information regarding PG-011 and its suitability for specific applications, please contact PeptiGrowth directly.
Alternative Peptide (FGFR1c agonist) – PeptiGrowth Inc. - What types of bioreactors have been successfully used? Examples include rotary shakers, stirred-tank reactors, and vertical-wheel bioreactors. Please contact us for further details.
- Has differentiation potential been evaluated? For 3D culture differentiation, both methods have been evaluated: dissociation of spheroids prior to differentiation and direct differentiation from intact spheroids. Successful differentiation into all three germ layers has been confirmed using both approaches.
- We are currently using StemFit for 2D culture. Can we transition to 3D culture? Yes, it is possible.
- Is a GMP-grade version available? If you are interested in GMP-compliant products, please contact us for further information.
— Precaution and Disclaimer —
StemFit™ Basic05 is for research use only and is not intended for human or animal diagnostic or therapeutic uses.
- Download
-
・Product Information (PDF [304KB])
・SDS (PDF [207KB])
・Brochure (PDF [2.6MB])







